Bavarian Nordic monkeypox vaccine wins EU approval

Published by
Reuters

OSLO (Reuters) – Danish biotechnology company Bavarian Nordic said on Monday the European Commission had given permission for its Imvanex vaccine to be marketed as protection against monkeypox, as recommended last week by the European Medicines Agency (EMA). The approval comes just one day after the World Health Organization issued a high-level alert declaring the rapidly spreading monkeypox outbreak as a global health emergency. “The availability of an approved vaccine can significantly improve nations’ readiness to fight emerging diseases, but only through investments and structured planning…

Read More

Leave a Reply